Mergers and acquisitions have been the driving force behind Danaher’s sustained growth for decades--the company has acquired hundreds of businesses since 1984. In the past several years, we've made notable additions to the Danaher portfolio, including Cepheid, Integrated DNA Technologies, AVT, and Pall. More than 50% of Danaher's total revenue today has been acquired in the past seven years.
But it’s not just about quantity—it’s about quality and strategic value. We look for innovative science and technology companies whose businesses will benefit from the Danaher Business System (DBS).
- Attractive Markets: We assess the market, including secular growth drivers and opportunities for consolidation.
- Company Profile: We analyze the company’s market position and potential, including brand strength and margin expansion opportunities.
- Value Creation: We consider potential in the context of DBS, our segments and our overall portfolio, including opportunities to extend global reach, advance technology and improve quality of life.
“We will continue to invest, as we have over a long period of time, in high-impact growth opportunities. We will continue to strengthen our market-leading positions and our overall portfolio, with a clear eye towards ensuring long-term, sustainable positions in attractive markets around the world.” Rainer Blair, President and Chief Executive Officer
We structure each acquisition carefully to meet the unique needs of both parties. Our decentralized operating structure preserves the strengths and independence of each business, while our global scope offers access to a wealth of resources, support and shared learnings. This balance positions our businesses to contribute to our shared purpose in unique and meaningful ways.
From adding exciting new technologies to contributing new perspectives and skills to our extended team, our focused acquisition strategy is essential to Helping Realize Life’s Potential for our customers, our companies and our shareholders.